Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
The analysis showed that the trial reached its primary endpoint with a 20% reduction in the risk of major adverse cardiovascular events in overweight or obese adults (patients without a history of diabetes) with a single weekly subcutaneous injection of 2.4 mg semaglutide
The dosage comparison chart shows equivalent doses side by side
Talk with our experts to start your weight loss journey
However, it's important to note some restrictions: those with a history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 should avoid taking this medication
What the new study found One of the reasons the new study is so exciting is its sheer size: The researchers analyzed data on more than 110,000 women ages 45 to 80
US$ 23.91
US$ 27.50
US$ 23.97
US$ 24.92
US$ 23.13
